Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Liraglutide in Children and Adolescents with Type 2 Diabetes.

Tamborlane WV, Barrientos-Pérez M, Fainberg U, Frimer-Larsen H, Hafez M, Hale PM, Jalaludin MY, Kovarenko M, Libman I, Lynch JL, Rao P, Shehadeh N, Turan S, Weghuber D, Barrett T; Ellipse Trial Investigators.

N Engl J Med. 2019 Aug 15;381(7):637-646. doi: 10.1056/NEJMoa1903822. Epub 2019 Apr 28.

PMID:
31034184
2.

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

Perkovic V, Jardine MJ, Neal B, Bompoint S, Heerspink HJL, Charytan DM, Edwards R, Agarwal R, Bakris G, Bull S, Cannon CP, Capuano G, Chu PL, de Zeeuw D, Greene T, Levin A, Pollock C, Wheeler DC, Yavin Y, Zhang H, Zinman B, Meininger G, Brenner BM, Mahaffey KW; CREDENCE Trial Investigators.

N Engl J Med. 2019 Jun 13;380(24):2295-2306. doi: 10.1056/NEJMoa1811744. Epub 2019 Apr 14.

3.

The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics.

Jardine MJ, Mahaffey KW, Neal B, Agarwal R, Bakris GL, Brenner BM, Bull S, Cannon CP, Charytan DM, de Zeeuw D, Edwards R, Greene T, Heerspink HJL, Levin A, Pollock C, Wheeler DC, Xie J, Zhang H, Zinman B, Desai M, Perkovic V; CREDENCE study investigators.

Am J Nephrol. 2017 Dec 13;46(6):462-472. doi: 10.1159/000484633. [Epub ahead of print]

4.

Factors Affecting Hemoglobin A1C in the Diagnosis of Diabetes and Prediabetes in Youth.

Hitt JM, Velasquez-Mieyer P, Neira C, Cowan P.

J Pediatr Nurs. 2016 Sep-Oct;31(5):511-8. doi: 10.1016/j.pedn.2016.03.020. Epub 2016 Apr 25.

PMID:
27132801
5.

Prediabetes and blood pressure effects on heart rate variability, QT-interval duration, and left ventricular hypertrophy in overweight-obese adolescents.

Lee S, Cowan PA, Wetzel GT, Velasquez-Mieyer P.

J Pediatr Nurs. 2011 Oct;26(5):416-27. doi: 10.1016/j.pedn.2010.08.008. Epub 2010 Sep 28.

PMID:
21930028
6.

A pilot study of QT interval analysis in overweight and obese youth.

Lee S, Cowan PA, Velasquez-Mieyer P.

Appl Nurs Res. 2012 Aug;25(3):218-21. doi: 10.1016/j.apnr.2010.11.003. Epub 2011 Jan 20.

7.

Calcium intake and body composition in African-American children and adolescents at risk for overweight and obesity.

Tylavsky FA, Cowan PA, Terrell S, Hutson M, Velasquez-Mieyer P.

Nutrients. 2010 Sep;2(9):950-64. doi: 10.3390/nu2090950. Epub 2010 Sep 10.

8.

Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial.

Bergenstal RM, Wysham C, Macconell L, Malloy J, Walsh B, Yan P, Wilhelm K, Malone J, Porter LE; DURATION-2 Study Group.

Lancet. 2010 Aug 7;376(9739):431-9. doi: 10.1016/S0140-6736(10)60590-9. Epub 2010 Jun 26.

PMID:
20580422
9.

Longitudinal study of muscle strength, quality, and adipose tissue infiltration.

Delmonico MJ, Harris TB, Visser M, Park SW, Conroy MB, Velasquez-Mieyer P, Boudreau R, Manini TM, Nevitt M, Newman AB, Goodpaster BH; Health, Aging, and Body.

Am J Clin Nutr. 2009 Dec;90(6):1579-85. doi: 10.3945/ajcn.2009.28047. Epub 2009 Oct 28.

10.

The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting.

Neira CP, Hartig M, Cowan PA, Velasquez-Mieyer PA.

J Am Acad Nurse Pract. 2009 Mar;21(3):173-8. doi: 10.1111/j.1745-7599.2008.00380.x.

PMID:
19302694
11.

Biphasic insulin aspart 30 for the treatment of type 1 diabetes mellitus.

Velásquez-Mieyer PA, Neira CP.

Expert Opin Pharmacother. 2008 Sep;9(13):2377-82. doi: 10.1517/14656566.9.13.2377 . Review.

PMID:
18710361
12.

Perceived barriers and facilitators to physical activity in kidney transplant recipients.

Sánchez ZV, Cashion AK, Cowan PA, Jacob SR, Wicks MN, Velasquez-Mieyer P.

Prog Transplant. 2007 Dec;17(4):324-31.

PMID:
18240699
13.

Racial disparity in glucagon-like peptide 1 and inflammation markers among severely obese adolescents.

Velásquez-Mieyer PA, Cowan PA, Pérez-Faustinelli S, Nieto-Martínez R, Villegas-Barreto C, Tolley EA, Lustig RH, Alpert BS.

Diabetes Care. 2008 Apr;31(4):770-5. doi: 10.2337/dc07-1525. Epub 2008 Jan 9.

PMID:
18184905
14.

Obesity and cardiometabolic syndrome in children.

Velasquez-Mieyer P, Neira CP, Nieto R, Cowan PA.

Ther Adv Cardiovasc Dis. 2007 Oct;1(1):61-81. doi: 10.1177/1753944707082800. Review.

PMID:
19124396
15.

Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.

Harden KA, Cowan PA, Velasquez-Mieyer P, Patton SB.

J Am Acad Nurse Pract. 2007 Jul;19(7):368-77.

PMID:
17680902
16.

Insulin dynamics predict body mass index and z-score response to insulin suppression or sensitization pharmacotherapy in obese children.

Lustig RH, Mietus-Snyder ML, Bacchetti P, Lazar AA, Velasquez-Mieyer PA, Christensen ML.

J Pediatr. 2006 Jan;148(1):23-9.

17.

Single- and multiple-dose pharmacokinetics of pioglitazone in adolescents with type 2 diabetes.

Christensen ML, Meibohm B, Capparelli EV, Velasquez-Mieyer P, Burghen GA, Tamborlane WV.

J Clin Pharmacol. 2005 Oct;45(10):1137-44.

PMID:
16172178
18.

Type 2 diabetes mellitus in children and adolescents: the new challenge.

Christensen ML, Rashed SM, Sinclair J, Cowan PA, Velasquez-Mieyer P, Burghen GA.

J Pediatr Pharmacol Ther. 2004 Jan;9(1):15-26. doi: 10.5863/1551-6776-9.1.15.

Supplemental Content

Loading ...
Support Center